tiprankstipranks
Immunome’s Promising Pipeline and Strategic Advancements Support Buy Rating
PremiumRatingsImmunome’s Promising Pipeline and Strategic Advancements Support Buy Rating
8d ago
Immunome’s 2024 Financial Results and Pipeline Progress
Premium
Company Announcements
Immunome’s 2024 Financial Results and Pipeline Progress
10d ago
Immunome price target lowered to $25 from $35 at Guggenheim
Premium
The Fly
Immunome price target lowered to $25 from $35 at Guggenheim
11d ago
Immunome $125M Spot Secondary; price range $7.50-$8.00
PremiumThe FlyImmunome $125M Spot Secondary; price range $7.50-$8.00
2M ago
Immunome announces $125M common stock offering
Premium
The Fly
Immunome announces $125M common stock offering
2M ago
Immunome CFO Relocation and Compensation Package Unveiled
Premium
Company Announcements
Immunome CFO Relocation and Compensation Package Unveiled
2M ago
Immunome reports Q3 EPS (78c), consensus (56c)
PremiumThe FlyImmunome reports Q3 EPS (78c), consensus (56c)
5M ago
IMNM Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
IMNM Earnings this Week: How Will it Perform?
5M ago
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
Premium
The Fly
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100